Led the content development and design of Foundation Medicine's investor pitch deck during my time at Duarte, curating a persuasive narrative arc to introduce their cutting-edge genomic platform. Transformed complex scientific content into sleek, purpose driven slides and a simple, cohesive story that was both inspiring and digestible to any audience.

Worked closely with executive leadership, scientific experts, compliance teams and other experts to ensure scientific rigor while maintaining investor-focused clarity.

Outcome:
Delivered a polished pitch deck that empowered Foundation Medicine to articulate their vision, strategy and value proposition to VCs and strategic investors. Foundation Medicine would eventually be acquired by a pharmaceutical giant valuing the company at $5.3B.